Science and Research

Biosynthetic cannabinoids use a fraction of extraction's cost, energy, water and biomass waste

Complaints of inadequate regulatory framework and prohibitive cost mirror criticisms in Canada

Cannabis is legal in Canada, but four main barriers block marginalized people from accessing the regulated market

A new study from researchers in New Zealand suggests even mild smoking habits can cause the illness

Male offspring are less vulnerable to cannabinoid exposure, but researchers aren't sure why

Not only is terpene information a cost-effective way to empower consumers, but it could play an important role in tracking Canada's sought-after genetics

Studies on the potential harms of weed use are often written off as propaganda, but dismissing research can be harmful in its own right

Medical and therapeutic benefits are clear even if scalability isn't

A new self-administration research model opens doors to fascinating questions that can't be explored in studies on people

Study found 61 per cent of participants felt a psychedelic-like high after taking placebo pill

As misinformation spreads like a virus, Cannalogue wants to conduct research to see if CBD can be used to fight the pandemic

Forget clinical studies, Cannametrics crunches user reviews to calculate how cannabinoids and terpenes will make you feel

Cannabimovone was shown to increase sensitivity to insulin

A university-run clinical trial showed a significant reduction of insomnia with minimal side effects

Intoxicated people should be considered vulnerable witnesses by police, lawyer says

GemmaCert could prevent mistaken drug busts and benefit medical cannabis patients

The free web service recommends your ideal strains based on a database of product descriptions and over 600 medical articles

The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex

Wind pollinating plants, like cannabis and hemp, don't provide enough nutrition to sustain bees

Dr. Ian Mitchell of Kamloops is calling out medical professionals across Canada for spreading misinformation on pot

Researchers found the cannabinoids exhibit anti-tumour properties

InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December

It may have been a sobering year for the legal weed industry, but cannabis still made major waves in society, politics and science in 2019

While the impairment may be different, the effect is the same: decreased reaction time and increased danger, according to a chief safety strategist

Almost 19 per cent of survey respondents with depression reported using pot over the last 30 days

RYAH Medtech is gearing up to enter more foreign markets and list on the CSE

Tetra Bio-Pharma’s stock continues to rise after announcing more trials at no additional cost to shareholders

Altas Biotechnologies Inc. donated nearly $300,000 to U of A for research over the next 2 years

Can cannabis ... is a new series where Mugglehead journalists investigate controversial claims about the uses of weed, in an effort to inform our readers and move the conversation forward.

Tissue culture uses less space and labour than the traditional trimming cloning method

The study showed inhaling cannabis reduced migraine severity by 49.6 per cent

But the authors of the research published in JAMA Psychiatry say it doesn't mean legalization is a bad idea

Questions remain as to whether impairment should be measured by blood-THC or cognitive functioning

First-of-its-kind research points to cannabis as a treatment for PTSD symptoms

Tilray shares jumped after announcing it successfully imported medical cannabis into the U.S. in support of a new clinical trial on its use for treating breast cancer drug side effects

Ikänik Farms is looking to go public in the next several months, and CEO Brian Baca tells Mugglehead its Pideka acquisition will "crush everybody coming out of Canada" with its low-cost cultivation and export potential.

Mugglehead talks to Everett Knight, executive vice president of strategy and investments at Valens, how the extraction company's focus on quality is helping it land big contracts ahead of Cannabis 2.0.

The two companies said they have been pouring in resources the last five months to develop water soluble pot drinks they expect will make a big splash in the $2.7 billion derivatives market.

Researchers at the Mayo Clinic examine lung tissue samples from 17 patients associated with the vaping health crisis that has sickened 1,080 Americans since April.

With more than 800 cases of vape-related lung disorders and 17 confirmed deaths, 800 cannabis companies signed a letter to Congress to regulate the industry to keep consumers safe.